Join our discussion group "Valuation in Life Sciences"
Categories > Reports
2009-01 Success Rates in Biotech - Going The Wrong Way The report "Success Rates in Biotech - Going The Wrong Way" summarizes our review of 211 public biotech companies comprising over 1,500 drug development projects Content and Figures
